Common mechanisms of drug interactions with sodium and T-type calcium channels

Molecular Pharmacology

Volumn 82, Issue 3, 2012, Pages 481-487

  Bladen, Chris ^a   Zamponi, Gerald W ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

A 803467; CALCIUM CHANNEL T TYPE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; SODIUM CHANNEL NAV1.8; SODIUM CHANNEL T TYPE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING SITE; DRUG MECHANISM; HUMAN; HUMAN CELL; HYPERPOLARIZATION; MEMBRANE DEPOLARIZATION; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NEUROMODULATION; PHENOTYPE; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; STEADY STATE; VASCULAR SMOOTH MUSCLE; WILD TYPE;

AMINO ACID SEQUENCE; ANILINE COMPOUNDS; ANIMALS; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELLS, CULTURED; DRUG INTERACTIONS; FURANS; HUMANS; ION CHANNEL GATING; KINETICS; MEMBRANE POTENTIALS; MOLECULAR SEQUENCE DATA; RATS; SODIUM; SODIUM CHANNELS;

EID: 84865263193     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.079715     Document Type: Article

References (36)

1. Altier C, Khosravani H, Evans RM, Hameed S, Peloquin JB, Vartian BA, Chen L, Beedle AM, Ferguson SS, Mezghrani A, et al. (2006) ORL1 receptor-mediated internalization of N-type calcium channels. Nat Neurosci 9:31-40.
2. Altier C and Zamponi GW (2004) Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol Sci 25:465-470.
3. Barton ME, Eberle EL, and Shannon HE (2005) The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil. Eur J Pharmacol 521:79-85.
4. Beedle AM, Hamid J, and Zamponi GW (2002) Inhibition of transiently expressed low- and high-voltage-activated calcium channels by trivalent metal cations. J Membr Biol 187:225-238.
5. Bender KJ, Uebele VN, Renger JJ, and Trussell LO (2012) Control of firing patterns through modulation of axon initial segment T-type calcium channels. J Physiol 590:109-118.
6. Blair NT and Bean BP (2002) Roles of tetrodotoxin (TTX)-sensitive Na+ current, TTX-resistant Na+ current, and Ca2+ current in the action potentials of nociceptive sensory neurons. J Neurosci 22:10277-10290.
7. Bourinet E, Alloui A, Monteil A, Barrère C, Couette B, Poirot O, Pages A, McRory J, Snutch TP, Eschalier A, et al. (2005) Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception. EMBO J 24:315-324.
8. Cain SM and Snutch TP (2010) Contributions of T-type calcium channel isoforms to neuronal firing. Channels (Austin) 4:475-482.
9. Catterall WA, Dib-Hajj S, Meisler MH, and Pietrobon D (2008) Inherited neuronal ion channelopathies: new windows on complex neurological diseases. J Neurosci 28:11768-11777.
10. Catterall WA, Perez-Reyes E, Snutch TP, and Striessnig J (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol Rev 57:411-425.
11. Choi S, Na HS, Kim J, Lee J, Lee S, Kim D, Park J, Chen CC, Campbell KP, and Shin HS (2007) Attenuated pain responses in mice lacking CaV3.2 T-type channels. Genes Brain Behav 6:425-431.
12. Cregg R, Momin A, Rugiero F, Wood JN, and Zhao J (2010) Pain channelopathies. J Physiol 588:1897-1904.
13. Cribbs L (2010) T-type calcium channel expression and function in the diseased heart. Channels (Austin) 4:447-452.
14. Cummins TR, Sheets PL, and Waxman SG (2007) The roles of sodium channels in nociception: implications for mechanisms of pain. Pain 131:243-257.
15. David LS, Garcia E, Cain SM, Thau E, Tyson JR, and Snutch TP (2010) Splice-variant changes of the Cav3.2 T-type calcium channel mediate voltage-dependent facilitation and associate with cardiac hypertrophy and development. Channels (Austin) 4:375-389.
16. Feng ZP, Doering CJ, Winkfein RJ, Beedle AM, Spafford JD, and Zamponi GW (2003) Determinants of inhibition of transiently expressed voltage-gated calcium channels by ω-conotoxins GVIA and MVIIA. J Biol Chem 278:20171-20178.
17. Heron SE, Khosravani H, Varela D, Bladen C, Williams TC, Newman MR, Scheffer IE, Berkovic SF, Mulley JC, and Zamponi GW. Scheffer IE, Berkovic SF, Mulley JC, and Zamponi GW (2007) Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. Ann Neurol 62:560-568.
18. Hildebrand ME, Smith PL, Bladen C, Eduljee C, Xie JY, Chen L, Fee-Maki M, Doering CJ, Mezeyova J, Zhu Y, et al. (2010) A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain. Pain 152:833-843.
19. Hille B (1977) Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. J Gen Physiol 69:497-515.
20. Ikeda H, Heinke B, Ruscheweyh R, and Sandkühler J (2003) Synaptic plasticity in spinal lamina I projection neurons that mediate hyperalgesia. Science 299:1237-1240.
21. Isom LL (2001) Sodium channel β subunits: anything but auxiliary. Neuroscientist 7:42-54.
22. Jarecki BW, Piekarz AD, Jackson JO 2nd, and Cummins TR (2010) Human voltage-gated sodium channel mutations that cause inherited neuronal and muscle channelopathies increase resurgent sodium currents. J Clin Invest 120:369-378.
23. Jarvis MF, Honore P, Shieh CC, Chapman M, Joshi S, Zhang XF, Kort M, Carroll W, Marron B, Atkinson R, et al. (2007) A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat. Proc Natl Acad Sci USA 104:8520-8525.
24. Khosravani H and Zamponi GW (2006) Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86:941-966.
25. Lipkind GM and Fozzard HA (2005) Molecular modeling of local anesthetic drug binding by voltage-gated sodium channels. Mol Pharmacol 68:1611-1622.
26. McGaraughty S, Chu KL, Scanio MJ, Kort ME, Faltynek CR, and Jarvis MF. Scanio MJC, Kort ME, and Jarvis MF (2008) A selective Nav1.8 sodium channel blocker, A-803467 [5-(4-chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide] , attenuates spinal neuronal activity in neuropathic rats. J Pharmacol Exp Ther 324:1204-1211.
27. Park J and Luo ZD (2010) Calcium channel functions in pain processing. Channels (Austin) 4:510-517.
28. Perez-Reyes E (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117-161.
29. Prescott SA and De Koninck Y (2002) Four cell types with distinctive membrane properties and morphologies in lamina I of the spinal dorsal horn of the adult rat. J Physiol 539:817-836.
30. Ragsdale DS, McPhee JC, Scheuer T, and Catterall WA (1994) Molecular determinants of state dependent block of Na channels by local anesthetics. Science 265:1724-7228.
31. Sheets PL, Heers C, Stoehr T, and Cummins TR (2008) Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine. J Pharmacol Exp Ther 326:89-99.
32. Wang W, Gu J, Li YQ, and Tao YX (2011) Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? Mol Pain 7:16.
33. Waxman SG, Cummins TR, Dib-Hajj S, Fjell J, and Black JA (1999) Sodium channels, excitability of primary sensory neurons, and the molecular basis of pain. Muscle Nerve 22:1177-1187.
34. Yarov-Yarovoy V, Brown J, Sharp EM, Clare JJ, Scheuer T, and Catterall WA (2001) Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na+ channel α subunit. J Biol Chem 276:20-27.
35. Yarov-Yarovoy V, McPhee JC, Idsvoog D, Pate C, Scheuer T, and Catterall WA. McPhee JC, Idsvoog D, Pate C, Scheuer T, and Catterall WA (2002) Role of amino acid residues in transmembrane segments IS6 and IIS6 of the Na+ channel α subunit in voltage-dependent gating and drug block. J Biol Chem 277:35393-35401.
36. Yu FH and Catterall WA (2004) The VGL-chanome: a protein superfamily specialized for electrical signaling and ionic homeostasis. Sci STKE 253:re15.